재발 및 난치성 다발성 골수종에서 Idecabtagene Vicleucel

Munshi 등(Wed,)이 이 문제를 연구했습니다.

www.synapsesocial.com/papers/69d74fec5f9a1dad5348fbfe — DOI: https://doi.org/10.1056/nejmoa2024850

Also consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. Treatment of relapsed and refractory multiple myeloma· 2016 · 177 citations
2. Current concepts in the diagnosis and management of cytokine release syndrome· 2014 · 2,776 citations
3. Effective Targeting of Multiple B-Cell Maturation Antigen–Expressing Hematological Malignances by Anti-B-Cell Maturation Antigen Chimeric Antigen Receptor T Cells· 2018 · 207 citations
4. Outcomes of patients with multiple myeloma refractory to CD38-targeted monoclonal antibody therapy· 2019 · 613 citations
5. Immunologic approaches for the treatment of multiple myeloma· 2017 · 37 citations